SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX is drawing attention after a sharp breakout to a 52-week high, with traders focused on heavy call buying and positioning ahead of the Q3 report. Buyout and short-squeeze theories are circulating, but remain speculation; others point to BRIUMVIs sales growth as the underlying driver.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Roots Hyundai Secure+ partnership is drawing attention after the product was identified as powered by Root, with traders focused on its potential to expand embedded, dealership-based insurance sales. Bulls see Hyundai and Kias vehicle sales as a significant distribution opportunity, while skeptics question how quickly the rollout can translate into policy growth amid recent concerns about declining policies in force.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons stronger-than-expected third-quarter results are driving the sharp rally, with traders highlighting growth in Dupixent and Eylea HD and the stocks breakout to a new high. The reaction is broadly bullish, though some note that declining legacy Eylea sales and biosimilar competition remain risks.

Cheniere Energy, Inc. engages in liquefied natural gas (LNG) related businesses. It owns and operates LNG terminals, develops, constructs, and operates liquefaction projects near Corpus Christi, Texas, and at the Sabine Pass LNG terminal. The company was founded by Charif Souki in 1983 and is headquartered in Houston, TX.

Cheniere Energy Inc.

Cheniere is drawing attention after strong quarterly results, higher full-year guidance and a dividend increase, fueling bullish momentum and fresh-high chatter. Some traders are taking profits and options positioning is mixed, reflecting caution after the run-up.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopify is drawing attention ahead of its quarterly results, with traders focused on GMV and take rate as well as whether payments-heavy growth can offset margin pressure and rising credit costs. The discussion is split between hopes for a strong report and concerns about the recent pullback and earnings risk.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Stockholm, Sweden.

Spotify Technology S.A.

Spotifys shares are drawing attention after rising sharply on Q3 results and an upbeat Q4 outlook, with traders focusing on subscriber growth, improving gross margin and stronger guided operating income despite an EPS miss. The rally has prompted bullish reactions, while skeptics question the valuation and higher expenses.

TRON (TRX) is a cryptocurrency launched in 2018. TRON has a current supply of 95,022,365,191.094644 with 95,022,375,662.737444 in circulation. The last known price of TRON is 0.30232528 USD and is down -8.04 over the last 24 hours. It is currently trading on 1389 active market(s) with $1,465,217,312.79 traded over the last 24 hours. More information can be found at https://trondao.org/.

Tron

TRON is drawing attention for its perceived resilience and steady upward trend compared with other cryptocurrencies, with traders sharing bullish breakout setups and pointing to stablecoin activity as support for the network. Others remain skeptical, citing its long periods of sideways trading and warning that the recent advance could give way to a pullback.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLakes BLA submission for sonelokimab in hidradenitis suppurativa has put FDA acceptance and the review timeline at the center of discussion. Traders are split between optimism about the drugs potential and a possible partnership or acquisition, and concerns about regulatory risk, competition, and the cost of commercializing it independently.

OFFICIAL TRUMP (TRUMP) is a cryptocurrency and operates on the Solana platform. OFFICIAL TRUMP has a current supply of 999,998,811.032761 with 281,866,747.320393 in circulation. The last known price of OFFICIAL TRUMP is 1.57555883 USD and is down -1.93 over the last 24 hours. It is currently trading on 744 active market(s) with $126,884,732.61 traded over the last 24 hours. More information can be found at https://gettrumpmemes.com/.

Trump For President

The Trump-themed meme coin is drawing attention amid its steep decline from earlier highs, with many traders calling it a pump-and-dump and pointing to losses among holders. A smaller bullish contingent sees the recent price strength as accumulation or a possible squeeze, while election-related speculation adds to the debate over demand.

Blue Owl Capital, Inc. operates as an alternative asset management firm. It provides investors access to asset management capital solutions through its Direct Lending and GP Capital Solutions products. The company offers a platform of capital solutions to both middle market companies and large alternative asset managers. The company was founded by Doug Irving Ostrover, Michael Rees and Craig W.Packer in 2009 and is headquartered in New York, NY.

Blue Owl Capital Inc - Ordinary Shares - Class A

Blue Owls Q3 results beat expectations, and traders are highlighting growth in assets under management, fee-related earnings, and managements outlook for future fee growth and dividend coverage. Bulls see room for a valuation recovery, while skeptics remain focused on private-credit redemption concerns and put-heavy options activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

LAZARD GLOBAL TOTAL RETURN AND INCOME FUND DECLARES MONTHLY DISTRIBUTION AND ISSUES ESTIMATED SOURCES OF THE DISTRIBUTION ANNOUNCED IN SEPTEMBER

LAZARD GLOBAL TOTAL RETURN AND INCOME FUND DECLARES MONTHLY DISTRIBUTION AND ISSUES ESTIMATED SOURCES OF THE DISTRIBUTION ANNOUNCED IN SEPTEMBER LAZARD GLOBAL TOTAL RETURN AND INCOME FUND DECLARES MONTHLY DISTRIBUTION AND ISSUES ESTIMATED SOURCES OF THE DISTRIBUTION ANNOUNCED IN SEPTEMBERPR...

Here's What Key Metrics Tell Us About Lazard (LAZ) Q3 Earnings

The headline numbers for Lazard (LAZ) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Lazard (LAZ) Misses Q3 Earnings and Revenue Estimates

Lazard (LAZ) delivered earnings and revenue surprises of -16.28% and -3.86%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Lazard Reports Third Quarter and Nine Month 2026 Results

Lazard Reports Third Quarter and Nine Month 2026 Results Lazard Reports Third Quarter and Nine Month 2026 ResultsPR NewswireNEW YORK, Oct. 22, 2026 NEW YORK, Oct. 22, 2026 /PRNewswire/ -- Lazard, Inc. (NYSE: LAZ) today reported net revenue on a U.S. GAAP basis of $814 million and adjusted net...

Lazard Declares Quarterly Dividend of $0.50 per Share

Lazard Declares Quarterly Dividend of $0.50 per Share Lazard Declares Quarterly Dividend of $0.50 per SharePR NewswireNEW YORK, Oct. 21, 2026 NEW YORK, Oct. 21, 2026 /PRNewswire/ -- Lazard, Inc. (NYSE: LAZ) today announced that its Board of Directors has voted to declare a quarterly dividend of...

What Analyst Projections for Key Metrics Reveal About Lazard (LAZ) Q3 Earnings

Besides Wall Street's top-and-bottom-line estimates for Lazard (LAZ), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2026.

Lazard CEO and Chairman Peter R. Orszag to Speak at the 2026 BMO Financials Conference

Lazard CEO and Chairman Peter R. Orszag to Speak at the 2026 BMO Financials Conference Lazard CEO and Chairman Peter R. Orszag to Speak at the 2026 BMO Financials ConferencePR NewswireNEW YORK, Oct. 20, 2026 NEW YORK, Oct. 20, 2026 /PRNewswire/ -- Lazard, Inc. (NYSE: LAZ) today announced Peter R...

Lazard Welcomes David Krap as Managing Director and Co-Head of European Consumer, Retail & Leisure

Lazard Welcomes David Krap as Managing Director and Co-Head of European Consumer, Retail & Leisure Lazard Welcomes David Krap as Managing Director and Co-Head of European Consumer, Retail & LeisurePR NewswireLONDON, Oct. 19, 2026LONDON, Oct. 19, 2026 /PRNewswire/ -- Lazard, Inc. (NYSE: LAZ) today...

Earnings Preview: Lazard (LAZ) Q3 Earnings Expected to Decline

Lazard (LAZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Lazard Reports September 2026 Assets Under Management

Lazard Reports September 2026 Assets Under Management Lazard Reports September 2026 Assets Under ManagementPR NewswireNEW YORK, Oct. 12, 2026NEW YORK, Oct. 12, 2026 /PRNewswire/ -- Lazard, Inc. (NYSE: LAZ) reported today that its preliminary assets under management ("AUM") as of September 30, 2026...

• Reported GAAP EPS of $0.36 down -35.71% YoY
• Reported revenue of $804.62M up 11.04% YoY
• Lazard aims to deliver an adjusted compensation ratio of 60% or below and an adjusted non-compensation ratio between 16% and 20%, with timing dependent on market conditions.

Lazards adjusted earnings declined year-over-year, compensation expense and its ratio rose, while Asset Management incentive fees fell to $1M from $9M and quarterly net outflows reached $2.3B.

Lazard reported record third-quarter Financial Advisory revenue, record year-to-date Asset Management gross inflows and positive nine-month net flows, while preparing Lazard CL's launch in early November.

Lazard, Inc. is a financial advisory and asset management firm, which engages in the provision of crafting solutions to the clients, including corporations, governments, institutions, partnerships, and individuals. It operates through the Financial Advisory and Asset Management segments. The Financial Advisory segment offers corporate, partnership, institutional, government, sovereign, and individual clients, an array of financial advisory services regarding mergers and acquisitions, restructurings, capital structure, capital raising, and corporate preparedness. The Asset Management segment provides global investment solutions and investment management services. The company was founded by Alexandre Lazard, Lazare Lazard, and Simon Lazard in 1848 and is headquartered in New York, NY.

Lazard Inc.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$38.35
Prev Close	$39.54
Open	$38.91
Dividend Yield	4.12%
50-Day Moving Average	$38.72
Beta	1.66
Avg. Volume	1.84M
PE Ratio	23.20

52-Week High	$58.75
52-Week Low	$34.13
Market Capitalization	$3.75B
EPS (Annual)	$2.37
Price to Book	3.95
Revenue Per Employee	$968,509.22

Feed

News

Sentiment

Earnings

Fundamentals

Info

LAZ Fundamentals